GreenLight SPAC Presentation Deck

Projected corporate financial metrics 2021-2025 ($ in millions) Revenue¹ EBITDA¹ Capital Expenditures Working Capital Investment 2021E $2 ($114) $14 $0 2022E $41 ($190) $71 $69 Investor Presentation | © 2021 GreenLight Biosciences. All rights reserved. GreenLight confidential. 2023E $186 ($11) $52 $64 2024E $231 ($23) $104 $61 2025E $849 $235 $32 $51 1. Non-GAAP financials based on management estimates. Modeling of EBITDA primarily reflects existing programs. Additional opportunities for investment will be considered and are not fully reflected in the EBITDA estimates. 40

View entire presentation